{
    "root": "351d4de0-4f1e-9ac7-e063-6394a90a6b21",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Losartan Potassium",
    "value": "20250514",
    "ingredients": [
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (1600000 WAMW)",
            "code": "RFW2ET671P",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00840"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "LOSARTAN POTASSIUM",
            "code": "3ST302B24A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6541"
        }
    ],
    "indications": {
        "text": "losartan potassium angiotensin ii receptor blocker ( arb ) indicated : treatment hypertension , lower blood pressure adults children greater 6 years old . lowering blood pressure reduces risk fatal nonfatal cardiovascular events , primarily strokes myocardial infarctions . ( 1.1 ) reduction risk stroke patients hypertension left ventricular hypertrophy . evidence benefit apply black patients . ( 1.2 ) treatment diabetic nephropathy elevated serum creatinine proteinuria patients type 2 diabetes history hypertension . ( 1.3 )",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            },
            {
                "text": "stroke (DOID:6713)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_6713"
            },
            {
                "text": "nephropathy (DOID:557)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_557"
            },
            {
                "text": "proteinuria (DOID:576)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_576"
            },
            {
                "text": "type 2 diabetes (DOID:9352)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9352"
            },
            {
                "text": "diabetes (DOID:9351)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9351"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "hypertension usual adult dose : 50 mg daily . ( 2.1 ) usual pediatric starting dose : 0.7 mg per kg daily ( 50 mg ) . ( 2.1 ) hypertensive patients left ventricular hypertrophy usual starting dose : 50 mg daily . ( 2.2 ) add hydrochlorothiazide 12.5 mg and/or increase losartan potassium 100 mg followed increase hydrochlorothiazide 25 mg blood pressure response needed . ( 2.2 , 14.2 ) nephropathy type 2 diabetic patients usual dose : 50 mg daily . ( 2.3 ) increase dose 100 mg daily blood pressure response needed . ( 2.3 )",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            },
            {
                "text": "nephropathy (DOID:557)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_557"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "losartan potassium tablets usp , white off-white film-coated tablets supplied follows : losartan shape engraving ( reverse ) ndc 68071-3846-3 bottle/30 bottle/90 bottle/500 bottle/1000 100 mg round ( 113 ) 68071-3846-3 store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp controlled room temperature ] . keep container tightly closed . protect light .",
    "adverseReactions": "losartan potassium contraindicated : patients hypersensitive component product . coadministration aliskiren patients diabetes .",
    "indications_original": "Losartan potassium is an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure in adults and children greater than 6 years old. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy. There is evidence that this benefit does not apply to Black patients. ( 1.2 ) Treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria in patients with type 2 diabetes and a history of hypertension. ( 1.3 )",
    "contraindications_original": "Hypertension Usual adult dose: 50 mg once daily. ( 2.1 ) Usual pediatric starting dose: 0.7 mg per kg once\u00a0daily (up to 50 mg). ( 2.1 ) Hypertensive Patients with Left Ventricular Hypertrophy Usual starting dose: 50 mg once daily. ( 2.2 ) Add hydrochlorothiazide 12.5 mg and/or increase losartan potassium to 100 mg followed by an increase to hydrochlorothiazide 25 mg if further blood pressure response is needed. ( 2.2 , 14.2 ) Nephropathy in Type 2 Diabetic Patients Usual dose: 50 mg once daily. ( 2.3 ) Increase dose to 100 mg once daily if further blood pressure response is needed. ( 2.3 )",
    "warningsAndPrecautions_original": "Losartan potassium tablets USP, are white to off-white film-coated tablets supplied as follows:\n                  \n                     \n                        \n                        \n                        \n                        \n                        \n                        \n                        \n                     \n                     \n                        \n                           \n                              \n                                 Losartan\n                              \n                           \n                           \n                              \n                                 Shape\n                              \n                           \n                           \n                              \n                                 Engraving (reverse)\n                              \n                           \n                           \n                              \n                                 NDC 68071-3846-3\n                              \n                           \n                        \n                        \n                           \n                              \n                                 Bottle/30\n                              \n                           \n                           \n                              \n                                 Bottle/90\n                              \n                           \n                           \n                              \n                                 Bottle/500\n                              \n                           \n                           \n                              \n                                 Bottle/1000\n                              \n                           \n                        \n                        \n                           \n                              \n                           \n                           \n                           \n                           \n                           \n                           \n                           \n                        \n                        \n                           \n                              100 mg\n                           \n                           \n                              round\n                           \n                           \n                              S (113)\n                           \n                           \n                              68071-3846-3\n                           \n                           \n                              \n                           \n                           \n                           \n                        \n                     \n                  \n                  Store at 20\u00b0C to 25\u00b0C (68\u00b0F to 77\u00b0F); excursions permitted to 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F) [see USP Controlled Room Temperature]. Keep container tightly closed. Protect from light.",
    "adverseReactions_original": "Losartan potassium is contraindicated:\n                  \n                     In patients who are hypersensitive to any component of this product.\n                     For coadministration with aliskiren in patients with diabetes.",
    "drug": [
        {
            "name": "Losartan Potassium",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6541"
        }
    ]
}